Company / Current Assets
NeoGenomics Laboratories, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$376.3M
FY2025
5-year range
$376.3M / $681.5M
FY2021-FY2025
Trend
-36.9%
vs FY2024
Sector context
#121 of 160
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s current assets of $376M is lower than 76% of companies in the Health Care sector (FY2025). Current Assets has declined for 4 consecutive years, from $682M in FY2021 to $376M in FY2025.
Based on SEC 10-K filings.
$376M in FY2025 with a 5-year CAGR of -3.5%.
Declined from $597M to $376M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -14.7%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 160This company $376.3M Sector average $5.2B
▼
-92.8% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -3.5%, indicating a declining trend.
- In FY2025, current assets decreased 36.9% year-over-year.
- Ranks #121 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $376.3M | -36.9% |
| FY2024 | $596.0M | -0.1% |
| FY2023 | $596.8M | -1.4% |
| FY2022 | $605.3M | -11.2% |
| FY2021 | $681.5M | +51.9% |
| FY2020 | $448.7M | +54.3% |
| FY2019 | $290.7M | +180.5% |
| FY2018 | $103.7M | +20.7% |
| FY2017 | $85.9M | +8.9% |
| FY2016 | $78.8M | -4.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026